Further research is necessary in order to develop new ligands that selectively target individual signaling pathways linked with GHS-R1A that could treat particular disorders (addiction, obesity etc.)with minimal side effects [68]. The gene discussed is GHSR; the disease is obesity due to melanocortin 4 receptor deficiency.